- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of LY500307 once daily for 24 weeks versus placebo treatment in improving the IPSS in men with LUTS and prostatic enlargement secondary to BPH.
Critère d'inclusion
- benign prostatic hyperplasia